322M 12.5/500 (Alogliptin benzoate and metformin hydrochloride 12.5 mg / 500 mg)
Pill imprint 322M 12.5/500 has been identified as Alogliptin benzoate and metformin hydrochloride 12.5 mg / 500 mg.
Alogliptin/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Alogliptin/metformin 12.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about alogliptin/metformin
- Other brands: Kazano
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.